From sectoral to horizontal public policies: the evolution of support for biotechnology in Europe, 1994-2001

Abstract : A number of policies have been developed in Europe, to facilitate the scientific and commercial development of high-technology sectors. How effective have these policies been? This paper addresses this question by exploring the impacts of policy on the development of biotechnology in the Member States. It analyses policy effects on the performance of different actor types that are crucial for a prospering biotechnology innovation system (start-ups, established firms, research labs, universities, and so on). The diversity of the measures and schemes to encourage the development of biotechnology reflects the diversity of the framework conditions, cultural preferences and political priorities in the Member States. Priority could have been given to research or to commercialisation. Incentive schemes and support policies could be dedicated to biotechnology as a sector, or targeted towards all innovative sectors, depending on national context. The organisation of research and development may be more or less efficient, depending on how funds are allocated and on the extent to which they are linked to priorities
Type de document :
Article dans une revue
Science and public policy, Oxford University Press, 2004, 31 (5), pp.397-406. 〈10.3152/147154304781779895〉
Liste complète des métadonnées

http://hal.grenoble-em.com/hal-00424320
Contributeur : Magali Michel <>
Soumis le : jeudi 15 octobre 2009 - 10:29:49
Dernière modification le : lundi 23 octobre 2017 - 08:50:02

Lien texte intégral

Identifiants

Collections

Citation

Vincent Mangematin. From sectoral to horizontal public policies: the evolution of support for biotechnology in Europe, 1994-2001. Science and public policy, Oxford University Press, 2004, 31 (5), pp.397-406. 〈10.3152/147154304781779895〉. 〈hal-00424320〉

Partager

Métriques

Consultations de la notice

267